A PHASE-I, SINGLE-BLIND STUDY TO DETERMINE THE SAFETY, TOLERANCE, PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTI-IGE RECOMBINANT HUMANIZED MONOCLONAL-ANTIBODY E25 (RHUMAB-E25) IN ADOLESCENTS AND CHILDREN WITH MODERATE TO SEVERE ALLERGIC-ASTHMA

Authors
BISBERG D FROEHLICH J SCHOENHOFF M MENDELSON J
Citation
D. Bisberg et al., A PHASE-I, SINGLE-BLIND STUDY TO DETERMINE THE SAFETY, TOLERANCE, PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTI-IGE RECOMBINANT HUMANIZED MONOCLONAL-ANTIBODY E25 (RHUMAB-E25) IN ADOLESCENTS AND CHILDREN WITH MODERATE TO SEVERE ALLERGIC-ASTHMA, Pediatric research, 39(4), 1996, pp. 39-39
Citations number
NO
Categorie Soggetti
Pediatrics
Journal title
Pediatric research → ACNP
ISSN journal
00313998
Volume
39
Issue
4
Year of publication
1996
Part
2
Pages
39 - 39
Database
ISI
SICI code
0031-3998(1996)39:4<39:APSSTD>2.0.ZU;2-R